AI-driven breast-cancer detection and personalized screening – On Target Podcast w/ Dr. Connie Lehman, Founder & CEO, Clairity
Connie Lehman, founder and CEO of Clairity, shares how AI-driven insights can improve early detection, personalize screening, and ultimately change the future of breast-cancer care.
Transforming Breast Cancer Screening Though AI
In this episode of the SBI podcast, host Dr. Karla Sepulveda welcomes Connie Lehman, MD, PhD to discuss how artificial intelligence is transforming breast cancer risk assessment. Dr. Lehman explains how AI-powered analysis of mammograms can identify women at elevated risk who may be missed by traditional risk models, paving the way for more personalized screening strategies. She also shares the story behind the development of the Mirai model and Clarity Breast, discusses recent NCCN guideline updates incorporating AI-based risk assessment, and explores the potential impact on screening recommendations, equity, and patient care.
Meeting Patients Where They Are
Interview with Clairity CEO Dr. Connie Lehman